Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Net Income (2016 - 2025)

Historic Net Income for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to -$9.2 million.

  • Assembly Biosciences' Net Income rose 433.79% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.5 million, marking a year-over-year increase of 553.13%. This contributed to the annual value of -$40.2 million for FY2024, which is 3438.13% up from last year.
  • Per Assembly Biosciences' latest filing, its Net Income stood at -$9.2 million for Q3 2025, which was up 433.79% from -$10.2 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Net Income peaked at -$8.8 million during Q1 2025, and registered a low of -$62.8 million during Q4 2021.
  • In the last 4 years, Assembly Biosciences' Net Income had a median value of -$11.2 million in 2024 and averaged -$17.5 million.
  • In the last 5 years, Assembly Biosciences' Net Income crashed by 46145.12% in 2021 and then skyrocketed by 5210.03% in 2024.
  • Over the past 4 years, Assembly Biosciences' Net Income (Quarter) stood at -$62.8 million in 2021, then skyrocketed by 82.54% to -$11.0 million in 2023, then grew by 5.72% to -$10.3 million in 2024, then increased by 11.02% to -$9.2 million in 2025.
  • Its last three reported values are -$9.2 million in Q3 2025, -$10.2 million for Q2 2025, and -$8.8 million during Q1 2025.